Matinas BioPharma Holdings, Inc.

MTNB · AMEX
Analyze with AI
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Assets
Cash & Equivalents$7,284$4,787$6,880$21,030
Short-Term Investments$0$8,969$21,933$28,592
Receivables$0$0$0$0
Inventory$0$0$0$0
Other Curr. Assets$741$1,787$5,719$1,371
Total Curr. Assets$8,025$15,543$34,532$50,993
Property Plant & Equip (Net)$2,156$5,008$5,734$5,780
Goodwill$0$1,336$1,336$1,336
Intangibles$2,260$3,017$3,017$3,017
Long-Term Investments$200$0$200$0
Tax Assets$0$0$34,047$0
Other NC Assets$0$200$0$200
Total NC Assets$4,616$9,561$44,334$10,333
Other Assets$0$0$0$0
Total Assets$12,641$25,104$78,866$61,326
Liabilities
Payables$95$514$618$937
Short-Term Debt$766$661$569$560
Tax Payable$0$0$0$0
Deferred Revenue$0$0$809$33
Other Curr. Liab.$1,805$1,447$2,290$2,818
Total Curr. Liab.$2,666$2,622$4,286$4,348
LT Debt$2,128$2,895$3,555$4,143
Deferred Rev, NC$0$0$0$0
Deferred Tax Liab, NC$257$341$34,388$341
Other NC Liab.$0$0$0$0
Total NC Liab.$2,385$3,236$37,943$4,484
Other Liabilities$0$0$0$0
Cap. Leases$2,894$3,556$3,555$4,703
Total Liabilities$5,051$5,858$42,229$8,832
Equity
Pref Stock$0$0$0$0
Common Stock$1$22$22$22
Retained Earnings-$199,824-$175,573-$152,631-$131,634
AOCI$0-$221-$824-$145
Other Equity$207,413$195,018$190,070$184,251
Total Equity$7,590$19,246$36,637$52,494
Supplemental Information
Minority Interest$0$0$0$0
Total Liab. & Tot. Equity$12,641$25,104$78,866$61,326
Net Debt-$4,390-$1,231-$2,756-$16,327
Matinas BioPharma Holdings, Inc. (MTNB) Financial Statements & Key Stats | AlphaPilot